Centro Médico Dra. De Salvo

Caba C1426ABP

0 studies enrolling now · 3 studies all time

What they study most

Colitis, Ulcerative, Pulmonary Arterial Hypertension, Ulcerative Colitis

Studies at this site

• A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed